Formulating Success: Morepen Ramps Up With 1,000 Med Rep Recruits

Unknown Apr 02, 2026 2 Views

Morepen Laboratories has chalked out a plan to hire over 1,000 medical representatives in the next three years to strengthen its formulations business. The company aims to take its India finished dosage business, currently valued at ₹325 crore, to ₹1,000 crore in revenues by 2030. Over 200 additions are envisaged for FY26 alone, with focus on more outreach to doctors, pharmacies, and patients in urban and rural India.

Chairman and MD Sushil Suri described this expansion as a "pivotal moment" in Morepen's growth strategy, citing its competitive pricing and robust product pipeline. The initiative is in parallel with India's pharmaceutical market growth, which is set to be $130 billion by 2030 with an 8.2% per annum growth rate.

The initiative positions Morepen as a leader in affordable healthcare while optimizing stakeholder returns through enhanced margins and market penetration.

Source: Business Standard, Economic Times, Rediff

Stay Ahead – Explore Now! India Rolls Out the Red Carpet for Investors—$100 Billion FDI Ambition Unveiled